Cargando…

A rationale for considering heart/brain axis control in neuropsychiatric disease

Neuropsychiatric diseases (NPD) represent a significant global disease burden necessitating innovative approaches to pathogenic understanding, biomarker identification and therapeutic strategy. Emerging evidence implicates heart/brain axis malfunction in NPD etiology, particularly via the autonomic...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrett, Lillian, Trümbach, Dietrich, Spielmann, Nadine, Wurst, Wolfgang, Fuchs, Helmut, Gailus-Durner, Valerie, Hrabě de Angelis, Martin, Hölter, Sabine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290621/
https://www.ncbi.nlm.nih.gov/pubmed/36538124
http://dx.doi.org/10.1007/s00335-022-09974-9
_version_ 1785062528983760896
author Garrett, Lillian
Trümbach, Dietrich
Spielmann, Nadine
Wurst, Wolfgang
Fuchs, Helmut
Gailus-Durner, Valerie
Hrabě de Angelis, Martin
Hölter, Sabine M.
author_facet Garrett, Lillian
Trümbach, Dietrich
Spielmann, Nadine
Wurst, Wolfgang
Fuchs, Helmut
Gailus-Durner, Valerie
Hrabě de Angelis, Martin
Hölter, Sabine M.
author_sort Garrett, Lillian
collection PubMed
description Neuropsychiatric diseases (NPD) represent a significant global disease burden necessitating innovative approaches to pathogenic understanding, biomarker identification and therapeutic strategy. Emerging evidence implicates heart/brain axis malfunction in NPD etiology, particularly via the autonomic nervous system (ANS) and brain central autonomic network (CAN) interaction. This heart/brain inter-relationship harbors potentially novel NPD diagnosis and treatment avenues. Nevertheless, the lack of multidisciplinary clinical approaches as well as a limited appreciation of molecular underpinnings has stymied progress. Large-scale preclinical multi-systemic functional data can therefore provide supplementary insight into CAN and ANS interaction. We here present an overview of the heart/brain axis in NPD and establish a unique rationale for utilizing a preclinical cardiovascular disease risk gene set to glean insights into heart/brain axis control in NPD. With a top-down approach focusing on genes influencing electrocardiogram ANS function, we combined hierarchical clustering of corresponding regional CAN expression data and functional enrichment analysis to reveal known and novel molecular insights into CAN and NPD. Through ‘support vector machine’ inquiries for classification and literature validation, we further pinpointed the top 32 genes highly expressed in CAN brain structures altering both heart rate/heart rate variability (HRV) and behavior. Our observations underscore the potential of HRV/hyperactivity behavior as endophenotypes for multimodal disease biomarker identification to index aberrant executive brain functioning with relevance for NPD. This work heralds the potential of large-scale preclinical functional genetic data for understanding CAN/ANS control and introduces a stepwise design leveraging preclinical data to unearth novel heart/brain axis control genes in NPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00335-022-09974-9.
format Online
Article
Text
id pubmed-10290621
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-102906212023-06-26 A rationale for considering heart/brain axis control in neuropsychiatric disease Garrett, Lillian Trümbach, Dietrich Spielmann, Nadine Wurst, Wolfgang Fuchs, Helmut Gailus-Durner, Valerie Hrabě de Angelis, Martin Hölter, Sabine M. Mamm Genome Article Neuropsychiatric diseases (NPD) represent a significant global disease burden necessitating innovative approaches to pathogenic understanding, biomarker identification and therapeutic strategy. Emerging evidence implicates heart/brain axis malfunction in NPD etiology, particularly via the autonomic nervous system (ANS) and brain central autonomic network (CAN) interaction. This heart/brain inter-relationship harbors potentially novel NPD diagnosis and treatment avenues. Nevertheless, the lack of multidisciplinary clinical approaches as well as a limited appreciation of molecular underpinnings has stymied progress. Large-scale preclinical multi-systemic functional data can therefore provide supplementary insight into CAN and ANS interaction. We here present an overview of the heart/brain axis in NPD and establish a unique rationale for utilizing a preclinical cardiovascular disease risk gene set to glean insights into heart/brain axis control in NPD. With a top-down approach focusing on genes influencing electrocardiogram ANS function, we combined hierarchical clustering of corresponding regional CAN expression data and functional enrichment analysis to reveal known and novel molecular insights into CAN and NPD. Through ‘support vector machine’ inquiries for classification and literature validation, we further pinpointed the top 32 genes highly expressed in CAN brain structures altering both heart rate/heart rate variability (HRV) and behavior. Our observations underscore the potential of HRV/hyperactivity behavior as endophenotypes for multimodal disease biomarker identification to index aberrant executive brain functioning with relevance for NPD. This work heralds the potential of large-scale preclinical functional genetic data for understanding CAN/ANS control and introduces a stepwise design leveraging preclinical data to unearth novel heart/brain axis control genes in NPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00335-022-09974-9. Springer US 2022-12-20 2023 /pmc/articles/PMC10290621/ /pubmed/36538124 http://dx.doi.org/10.1007/s00335-022-09974-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Garrett, Lillian
Trümbach, Dietrich
Spielmann, Nadine
Wurst, Wolfgang
Fuchs, Helmut
Gailus-Durner, Valerie
Hrabě de Angelis, Martin
Hölter, Sabine M.
A rationale for considering heart/brain axis control in neuropsychiatric disease
title A rationale for considering heart/brain axis control in neuropsychiatric disease
title_full A rationale for considering heart/brain axis control in neuropsychiatric disease
title_fullStr A rationale for considering heart/brain axis control in neuropsychiatric disease
title_full_unstemmed A rationale for considering heart/brain axis control in neuropsychiatric disease
title_short A rationale for considering heart/brain axis control in neuropsychiatric disease
title_sort rationale for considering heart/brain axis control in neuropsychiatric disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290621/
https://www.ncbi.nlm.nih.gov/pubmed/36538124
http://dx.doi.org/10.1007/s00335-022-09974-9
work_keys_str_mv AT garrettlillian arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT trumbachdietrich arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT spielmannnadine arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT wurstwolfgang arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT fuchshelmut arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT gailusdurnervalerie arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT hrabedeangelismartin arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT holtersabinem arationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT garrettlillian rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT trumbachdietrich rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT spielmannnadine rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT wurstwolfgang rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT fuchshelmut rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT gailusdurnervalerie rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT hrabedeangelismartin rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease
AT holtersabinem rationaleforconsideringheartbrainaxiscontrolinneuropsychiatricdisease